GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Restart Life Sciences Corp (XCNQ:HEAL.X) » Definitions » Institutional Ownership

Restart Life Sciences (XCNQ:HEAL.X) Institutional Ownership : 2.93% (As of Dec. 11, 2024)


View and export this data going back to 2006. Start your Free Trial

What is Restart Life Sciences Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Restart Life Sciences's institutional ownership is 2.93%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Restart Life Sciences's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Restart Life Sciences's Float Percentage Of Total Shares Outstanding is 0.00%.


Restart Life Sciences Institutional Ownership Historical Data

The historical data trend for Restart Life Sciences's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Restart Life Sciences Institutional Ownership Chart

Restart Life Sciences Historical Data

The historical data trend for Restart Life Sciences can be seen below:

2019-02-28 2019-03-31 2019-04-30 2019-05-31 2019-06-30 2021-01-31 2021-02-28 2021-03-31 2021-04-30 2021-05-31
Institutional Ownership 0.31 0.31 0.31 0.31 0.31 0.98 3.88 3.40 3.20 2.93

Restart Life Sciences Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Restart Life Sciences Business Description

Traded in Other Exchanges
Address
700-838 West Hastings Street, Vancouver, BC, CAN, V6C 0A6
Restart Life Sciences Corp is a Canadian life sciences company dedicated to addressing today's health challenges with wellness solutions. It is focus is on creating health foods that address the needs of this community. Its Flagship developments includes Autism Spectrum, Health-Related Foods, Psilocybin Clinical Trial for Fragile X Syndrome, Orphan Drug Designation (FDA and EMA).
Executives
Derek Lloyd Harry Ivany 10% Security Holder, Director, Senior Officer
Steven Feldman Director
William Rascan Director, Senior Officer

Restart Life Sciences Headlines

No Headlines